FDA Inspection 1231316 — Peyman Saadat MD, Inc.
The FDA completed an inspection of Peyman Saadat MD, Inc. on Feb 20, 2024 in West Hollywood, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- West Hollywood, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12238 | 21 CFR 1271.55(b)(1) | Statement re: certified testing lab |
| 12426 | 21 CFR 1271.265(c)(2) | Improperly released for distribution |